创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels: characteristics of in vitro detection platforms

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-21 13:56
  • Views:

(Summary description)With today's rapid advances in science and technology, biomedical research is moving to unprecedented heights. As an advanced biotechnology company dedicated to providing innovative research tools and services, InnoModels has launched its latest in vitro assay platform to provide scientists with an efficient and accurate means of research. In this article, we will introduce the features and advantages of the InnoModels in vitro assay platform

InnoModels: characteristics of in vitro detection platforms

(Summary description)With today's rapid advances in science and technology, biomedical research is moving to unprecedented heights. As an advanced biotechnology company dedicated to providing innovative research tools and services, InnoModels has launched its latest in vitro assay platform to provide scientists with an efficient and accurate means of research. In this article, we will introduce the features and advantages of the InnoModels in vitro assay platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-02-21 13:56
  • Views:
Information

With today's rapid advances in science and technology, biomedical research is moving to unprecedented heights. As an advanced biotechnology company dedicated to providing innovative research tools and services, InnoModels has launched its latest in vitro assay platform to provide scientists with an efficient and accurate means of research. In this article, we will introduce the features and advantages of the InnoModels in vitro assay platform.
1. Diverse testing services
InnoModels' in vitro assay platform covers a wide range of assay services, including but not limited to cytotoxicity, cell proliferation, cell migration and cell invasion. Whether it is basic cell biology research or drug screening and development, the platform can provide a variety of assays and experimental programs to meet different research needs.
2. High throughput and automation
The in vitro assay platform utilizes high-throughput and automated technology, which can handle a large number of samples at the same time, improving experimental efficiency and reducing human error. This high degree of automation allows researchers to quickly conduct large-scale experiments and speed up the process of scientific research.
3. High sensitivity and accuracy
InnoModels' in vitro assay platform is highly sensitive and accurate, capable of detecting subtle cellular reactions and changes. Whether it is a small cytotoxic effect or a small difference in cell proliferation, the platform can provide reliable data support and accurate results for researchers.

 


4. Customized Experimental Design
The platform supports customized experimental design, allowing researchers to choose the appropriate assay and experimental protocol according to their own research needs. Whether it is a screening experiment for a specific drug or a study of a specific cell behavior, the most suitable experimental protocol can be designed by working with the professional team of Thermo Scientific.
5. Complete data analysis and reporting
In addition to providing testing services, InnoModels also provides perfect data analysis and reporting services. Researchers can view the experimental results intuitively through the platform and get professional data analysis and interpretation to help them better understand the experimental results and guide their next research direction.
Conclusion
With its diverse testing services, high-throughput automation technology, high sensitivity and accuracy, customized experimental design, and comprehensive data analysis and reporting services, the InnoModels in vitro assay platform has become a shining star in the field of biomedical research. It provides scientists with a comprehensive, efficient and accurate research platform, and promotes the continuous innovation and development of the life science field.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司